FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101307 [Registered on: 16/01/2026] Trial Registered Prospectively
Last Modified On: 04/07/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [occupational therapy ]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Occupational Therapy–Based Interventions for Vertigo- A Prospective Outcome Study 
Scientific Title of Study   Prospective study to determine the effectiveness of occupational therapy intervention on occupational performance among vertigo pastients 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jane Benita 
Designation  PG 2nd year 
Affiliation  sri ramachandra institute of higher education and research 
Address  Ramachandra Medical college,Trunk rd, Sri Ramachandra Nagar,porur,Chennai 600116
Ramachandra Medical college,Trunk rd, Sri Ramachandra Nagar,porur,Chennai 600116
Chennai
TAMIL NADU
632001
India 
Phone  8220046779  
Fax    
Email  janebenita7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Loganathan S 
Designation  Assistant Professor 
Affiliation  sri ramachandra institute of higher education and research (DU) 
Address  Ramachandra Medical college,Trunk rd, Sri Ramachandra Nagar,porur,Chennai 600116
Ramachandra Medical college,Trunk rd, Sri Ramachandra Nagar,porur,Chennai 600116
Chennai
TAMIL NADU
600116
India 
Phone  9841958099  
Fax    
Email  loganathanot@sriramachandra.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr. Loganathan S 
Designation  Assistant Professor 
Affiliation  Sri ramachandra institute of higher education and research(Du) 
Address  Ramachandra Medical college,Trunk rd, Sri Ramachandra Nagar,porur,Chennai 600116
Ramachandra Medical college,Trunk rd, Sri Ramachandra Nagar,porur,Chennai 600116
Chennai
TAMIL NADU
600116
India 
Phone  9841958099  
Fax    
Email  loganathanot@sriramachandra.edu.in  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Jane Benita 
Address  No.1, Ramachandra Nagar, Sri Ramachandra Nagar, Chennai, Tamil Nadu 600116  
Type of Sponsor  Other [self ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Loganathan   Sri Ramachandra Hospital  Ramachandra Medical College, Trunk Rd, Sri Ramachandra Nagar, Porur, Chennai, Tamil Nadu 600116
Chennai
TAMIL NADU 
9841958099

loganathanot@sriramachandra.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SRMC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F01-F99||Mental, Behavioral and Neurodevelopmental disorders, (2) ICD-10 Condition: F01-F99||Mental, Behavioral and Neurodevelopmental disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  occupational therapy intervention   Acute intervention: Focuses on symptom control, education, safe positioning, gentle visual–vestibular exercises, static balance activities, relaxation, and modified ADL training to reduce dizziness, prevent fear, and ensure safety. 
Comparator Agent  occupational therapy intervention   Chronic intervention: Emphasizes vestibular adaptation, dynamic balance training, functional task practice, dual-task activities, endurance building, confidence enhancement, and community reintegration to restore independence. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Clinically diagnosed with vertigo by an ENT specialist or neurologist including (Benign Paroxysmal Positional Vertigo, vestibular neuritis, or central vertigo).
2. Adults aged 18 to 65 years will be included.
3. Both acute and chronic cases.
4. Montreal Cognitive Assessment (MoCA) score greater or equal to 26 (to ensure participants can actively engage in therapy tasks).
 
 
ExclusionCriteria 
Details  1. Participants with any other significant medical, neurological, psychiatric and orthopedic conditions will be excluded.
2. Severe physical impairments that would prevent active participation in intervention.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1. To evaluate the effectiveness of occupational therapy interventions in individuals diagnosed with vertigo.  12 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the therapeutic outcomes of occupational therapy between acute & chronic vertigo cases  12 weeks 
To reduce vertigo-related symptoms & improve occupational performance in affected individuals.  12 weeks  
To evaluate the effectiveness of occupational therapy interventions in individuals diagnosed with vertigo.  12 weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/01/2026 
Date of Study Completion (India) 15/06/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 15/06/2026 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

v  After the approval of the Institutional Ethics Committee.

v  The participants will be selected using the screening tools.

v  Participants will be explained about the benefits and risks of the study and will be obtained a written informed consent in accordance with the guidelines of the Ethics Committee.

v  Participants who meet with the selection criteria will be divided into two Group:

Group 1 (Acute Vertigo): Onset of vertigo symptoms within the past 4 weeks

Group 2 (Chronic Vertigo): Vertigo symptoms persisting for more than 3 months    

v  Intervention program will be provided.

v  The pre and post-test scores will be evaluated using the outcome measures.

v  The data will be analyzed and the results will be interpreted.

 
Close